Categories Earnings, Health Care

What to expect when UnitedHealth reports Q3 earnings

UnitedHealth Group (NYSE: UNH) is scheduled to report third quarter 2019 earnings on Tuesday, October 15, before the market opens. Analysts forecast the company will report earnings of $3.75 per share on revenue of $59.7 billion. This compares to earnings of $3.41 per share on revenue of $56.5 billion reported in the prior-year period.

In the trailing four quarters, the company has consistently beat earnings estimates and this trend can be expected to continue in the to-be-reported quarter. The strength in the Medicare and Optum businesses is likely to continue in the third quarter while membership growth maintains its momentum.

UnitedHealth Group (UNH) reports Q2 2019 earnings results

The company is likely to benefit from its investments in growth initiatives and strategic acquisitions. The efficient management of medical costs is also likely to help the quarterly results. Investments in artificial intelligence and other technologies are gaining prominence in the health industry.

Also read: Delta Air Lines Q3 2019 Earnings Report

In the second quarter of 2019, UnitedHealth Group beat market expectations for earnings while revenues were in line with estimates. Total revenues grew 8% year-over-year to $60.6 billion and adjusted EPS improved by 15% to $3.60. Revenue results were driven by double-digit growth at UnitedHealthcare Medicare & Retirement, OptumRx and OptumHealth. Revenues grew 6% in the UnitedHealthcare segment and 13% in the Optum segment.

For fiscal year 2019, UnitedHealth expects GAAP EPS of $13.95-14.15 and adjusted EPS of $14.70-14.90.

Shares of UnitedHealth have fallen over 10% year-to-date. However, the majority of analysts have rated the stock as Buy and it has an average price target of $290.62.

Browse through our earnings calendar and get all scheduled earnings announcements, analyst/investor conference and much more!

Most Popular

Cost reduction has become a priority for FedEx (FDX) after a challenging quarter

Shares of FedEx Corporation (NYSE: FDX) were up 1% on Tuesday. The stock has dropped 44% year-to-date and 34% over the past 12 months. The company delivered mixed results for

Prime Medicine is the next big biotech to pursue IPO. Here’s all you need to know

After a soft start to the year, the IPO market has witnessed muted activity so far though a few big companies entered the stock market. On the heels of AIG

Stock Watch: Is Darden Restaurants a good buy after earnings?

After a prolonged slowdown, the restaurant industry is returning to normal patterns but macroeconomic uncertainties and high inflation are currently playing spoilsport for it. While the pandemic-related slump forced many

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top